News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DFine Initiates Randomized Clinical Study to Evaluate Advanced Radiofrequency Technology for the Treatment of Spinal Fractures


11/15/2011 10:32:27 AM

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced the initiation of a prospective randomized clinical study to evaluate the clinical effectiveness of minimally invasive augmentation procedures to treat debilitating, painful vertebral compression fractures (VCFs). PRIORi-T (Prospective Randomized Investigation Of Radio Frequency Targeted Vertebral Augmentation) is a post-market, clinical study that will compare the radiofrequency targeted vertebral augmentation™ (RF-TVA) procedure to non-operative management (conservative care) in properly diagnosed osteoporotic VCFs within six weeks of onset.

Read at BioSpace.com


comments powered by Disqus
DFine
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES